The mammalian target of rapamycin pathway and its role in molecular nutrition regulationJUN LIAN; YAN, Xiang-Hua; JIAN PENG et al.Molecular nutrition & food research (Print). 2008, Vol 52, Num 4, pp 393-399, issn 1613-4125, 7 p.Article

Akt promotes increased mammalian cell size by stimulating protein synthesis and inhibiting protein degradationFARIDI, Jesika; FAWCETT, Janet; LIHONG WANG et al.American journal of physiology. Endocrinology and metabolism. 2003, Vol 48, Num 5, pp E964-E972, issn 0193-1849Article

Auf dem Weg zum Verständnis der ImmunusuppressionKESSLER, H; MIERKE, D. F; DONALD, D et al.Angewandte Chemie. 1991, Vol 103, Num 8, pp 968-969, issn 0044-8249Article

From Node to Pathway Blockade: Lessons Learned From Targeting Mammalian Target of RapamycinHIDALGO, Manuel.Journal of clinical oncology. 2012, Vol 30, Num 1, pp 85-87, issn 0732-183X, 3 p.Article

Placental DEPTOR as a stress sensor during pregnancyMPARMPAKAS, Dionisis; ZACHARIADES, Elena; GOUMENOU, Anastasia et al.Clinical science (1979). 2012, Vol 122, Num 7-8, pp 349-359, issn 0143-5221, 11 p.Article

Involvement of mTORC1 and mTORC2 in regulation of glioblastoma multiforme growth and motilityGULATI, Nicholas; KARSY, Michael; ALBERT, Ladislau et al.International journal of oncology. 2009, Vol 35, Num 4, pp 731-740, issn 1019-6439, 10 p.Article

RapamycinBOLLINGER, R. R.Clinical transplantation. 1991, Vol 5, Num 6, pp 527-529, issn 0902-0063, 2Article

Prognostic Significance of MTOR Pathway Component Expression in Neuroendocrine TumorsZHI RONG QIAN; TER-MINASSIAN, Monica; XIHONG LIN et al.Journal of clinical oncology. 2013, Vol 31, Num 27, pp 3418-3425, issn 0732-183X, 8 p.Article

Spatial Coupling of mTOR and Autophagy Augments Secretory PhenotypesNARITA, Masako; YOUNG, Andrew R. J; TAVARE, Simon et al.Science (Washington, D.C.). 2011, Vol 332, Num 6032, pp 966-970, issn 0036-8075, 5 p.Article

Temsirolimus, an Inhibitor of Mammalian Target of RapamycinRINI, Brian I.Clinical cancer research. 2008, Vol 14, Num 5, pp 1286-1290, issn 1078-0432, 5 p.Article

Immunosuppressive drug rapamycin restores sporulation competence in industrial yeastsNAKAZAWA, Nobushige; NIIJIMA, Seiko; TANAKA, Yukari et al.Journal of bioscience and bioengineering. 2012, Vol 113, Num 4, pp 491-495, issn 1389-1723, 5 p.Article

Time now to TORC the TORC? New developments in mTOR pathway inhibition in lymphoid malignanciesEYRE, Toby A; COLLINS, Graham P; GOLDSTONE, Anthony H et al.British journal of haematology. 2014, Vol 166, Num 3, pp 336-351, issn 0007-1048, 16 p.Article

Rapamycin-mediated FOXO1 Inactivation Reduces the Anticancer Efficacy of RapamycinABDELNOUR-BERCHTOLD, Etienne; CERANTOLA, Yannick; ROULIN, Didier et al.Anticancer research. 2010, Vol 30, Num 3, pp 799-804, issn 0250-7005, 6 p.Article

FDG uptake is a surrogate marker for defining the optimal biological dose of the mTOR inhibitor everolimus in vivoCEJKA, D; KUNTNER, C; MUELLER, M et al.British journal of cancer. 2009, Vol 100, Num 11, pp 1739-1745, issn 0007-0920, 7 p.Article

Rapamycin inhibits F-actin reorganization and phosphorylation of focal adhesion proteinsLIU, L; CHEN, L; CHUNG, J et al.Oncogene (Basingstoke). 2008, Vol 27, Num 37, pp 4998-5010, issn 0950-9232, 13 p.Article

Prognostic Impact of the Activation Status of the Akt/mTOR Pathway in Synovial SarcomaSETSU, Nokitaka; KOHASHI, Kenichi; ODA, Yoshinao et al.Cancer. 2013, Vol 119, Num 19, pp 3504-3513, issn 0008-543X, 10 p.Article

Immunosuppressive macrolidesSTÜTZ, A.Transplantation proceedings. 1992, Vol 24, Num 4, pp 22-25, issn 0041-1345, SUP2Conference Paper

Isolation of two immunosuppressive metabolites after in vitro metabolism of rapamycinCHRISTIANS, U; SATTLER, M; SCHIEBEL, H. M et al.Drug metabolism and disposition. 1992, Vol 20, Num 2, pp 186-191, issn 0090-9556Article

Preliminary Characterization of Oral Lesions Associated With Inhibitors of Mammalian Target of Rapamycin in Cancer PatientsSONIS, Stephen; TREISTER, Nathaniel; CHAWLA, Sant et al.Cancer. 2010, Vol 116, Num 1, pp 210-215, issn 0008-543X, 6 p.Article

Lithium induces clearance of protease resistant prion protein in prion-infected cells by induction of autophagyHEISEKE, Andreas; AGUIB, Yasmine; RIEMER, Constanze et al.Journal of neurochemistry. 2009, Vol 109, Num 1, pp 25-34, issn 0022-3042, 10 p.Article

Reversible isomerization of rapamycin demonstrated by liquid chromatographyNISHIKAWA, T; SUZUKI, S; OHTANI, H et al.Journal of antibiotics (Tokyo. 1968). 1994, Vol 47, Num 12, pp 1554-1556, issn 0021-8820Article

An anti-aging drug today : from senescence-promoting genes to anti-aging pillBLAGOSKLONNY, Mikhail V.Drug discovery today. 2007, Vol 12, Num 5-6, pp 218-224, issn 1359-6446, 7 p.Article

Preventive and therapeutic effects of rapamycin, a mammalian target of rapamycin inhibitor, on food allergy in miceYAMAKI, K; YOSHINO, S.Allergy (Copenhagen). 2012, Vol 67, Num 10, pp 1259-1270, issn 0105-4538, 12 p.Article

Targeting of mTOR is associated with decreased growth and decreased VEGF expression in acute myeloid leukaemia cellsBÖHM, A; AICHBERGER, K. J; GLEIXNER, K. V et al.European journal of clinical investigation. 2009, Vol 39, Num 5, pp 395-405, issn 0014-2972, 11 p.Article

A simple and efficient route to the FKBP-binding domain from rapamycinWEI LI; BHAT, Shridhar; LIU, Jun O et al.Tetrahedron letters. 2011, Vol 52, Num 39, issn 0040-4039, 4980, 5070-5072 [4 p.]Article